196 related articles for article (PubMed ID: 26025660)
1. Co-operative binding assay for the characterization of mGlu4 allosteric modulators.
Poutiainen P; Kil KE; Zhang Z; Kuruppu D; Tannous B; Brownell AL
Neuropharmacology; 2015 Oct; 97():142-8. PubMed ID: 26025660
[TBL] [Abstract][Full Text] [Related]
2. Discovery, Synthesis, and Preclinical Characterization of N-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4).
Engers DW; Blobaum AL; Gogliotti RD; Cheung YY; Salovich JM; Garcia-Barrantes PM; Daniels JS; Morrison R; Jones CK; Soars MG; Zhuo X; Hurley J; Macor JE; Bronson JJ; Conn PJ; Lindsley CW; Niswender CM; Hopkins CR
ACS Chem Neurosci; 2016 Sep; 7(9):1192-200. PubMed ID: 27075300
[TBL] [Abstract][Full Text] [Related]
3. Molecular determinants of positive allosteric modulation of the human metabotropic glutamate receptor 2.
Farinha A; Lavreysen H; Peeters L; Russo B; Masure S; Trabanco AA; Cid J; Tresadern G
Br J Pharmacol; 2015 May; 172(9):2383-96. PubMed ID: 25571949
[TBL] [Abstract][Full Text] [Related]
4. Identification of positive allosteric modulators VU0155094 (ML397) and VU0422288 (ML396) reveals new insights into the biology of metabotropic glutamate receptor 7.
Jalan-Sakrikar N; Field JR; Klar R; Mattmann ME; Gregory KJ; Zamorano R; Engers DW; Bollinger SR; Weaver CD; Days EL; Lewis LM; Utley TJ; Hurtado M; Rigault D; Acher F; Walker AG; Melancon BJ; Wood MR; Lindsley CW; Conn PJ; Xiang Z; Hopkins CR; Niswender CM
ACS Chem Neurosci; 2014 Dec; 5(12):1221-37. PubMed ID: 25225882
[TBL] [Abstract][Full Text] [Related]
5. Impact of allosteric modulation: Exploring the binding kinetics of glutamate and other orthosteric ligands of the metabotropic glutamate receptor 2.
Doornbos MLJ; Vermond SC; Lavreysen H; Tresadern G; IJzerman AP; Heitman LH
Biochem Pharmacol; 2018 Sep; 155():356-365. PubMed ID: 30028996
[TBL] [Abstract][Full Text] [Related]
6. A novel class of succinimide-derived negative allosteric modulators of metabotropic glutamate receptor subtype 1 provides insight into a disconnect in activity between the rat and human receptors.
Cho HP; Engers DW; Venable DF; Niswender CM; Lindsley CW; Conn PJ; Emmitte KA; Rodriguez AL
ACS Chem Neurosci; 2014 Jul; 5(7):597-610. PubMed ID: 24798819
[TBL] [Abstract][Full Text] [Related]
7. Distinct effects of mGlu4 receptor positive allosteric modulators at corticostriatal vs. striatopallidal synapses may differentially contribute to their antiparkinsonian action.
Gubellini P; Melon C; Dale E; Doller D; Kerkerian-Le Goff L
Neuropharmacology; 2014 Oct; 85():166-77. PubMed ID: 24866785
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.
Lundström L; Bissantz C; Beck J; Dellenbach M; Woltering TJ; Wichmann J; Gatti S
Neuropharmacology; 2016 Dec; 111():253-265. PubMed ID: 27590915
[TBL] [Abstract][Full Text] [Related]
9. Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers.
Niswender CM; Jones CK; Lin X; Bubser M; Thompson Gray A; Blobaum AL; Engers DW; Rodriguez AL; Loch MT; Daniels JS; Lindsley CW; Hopkins CR; Javitch JA; Conn PJ
ACS Chem Neurosci; 2016 Sep; 7(9):1201-11. PubMed ID: 27441572
[TBL] [Abstract][Full Text] [Related]
10. Functional modulation of G-protein coupled receptors during Parkinson disease-like neurodegeneration.
Jenkins BG; Zhu A; Poutiainen P; Choi JK; Kil KE; Zhang Z; Kuruppu D; Aytan N; Dedeoglu A; Brownell AL
Neuropharmacology; 2016 Sep; 108():462-73. PubMed ID: 26581500
[TBL] [Abstract][Full Text] [Related]
11. Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.
Lundström L; Bissantz C; Beck J; Dellenbach M; Woltering TJ; Wichmann J; Gatti S
Neuropharmacology; 2017 Mar; 115():115-127. PubMed ID: 28216000
[TBL] [Abstract][Full Text] [Related]
12. Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationships.
Gregory KJ; Noetzel MJ; Rook JM; Vinson PN; Stauffer SR; Rodriguez AL; Emmitte KA; Zhou Y; Chun AC; Felts AS; Chauder BA; Lindsley CW; Niswender CM; Conn PJ
Mol Pharmacol; 2012 Nov; 82(5):860-75. PubMed ID: 22863693
[TBL] [Abstract][Full Text] [Related]
13. Effect of Novel Allosteric Modulators of Metabotropic Glutamate Receptors on Drug Self-administration and Relapse: A Review of Preclinical Studies and Their Clinical Implications.
Caprioli D; Justinova Z; Venniro M; Shaham Y
Biol Psychiatry; 2018 Aug; 84(3):180-192. PubMed ID: 29102027
[TBL] [Abstract][Full Text] [Related]
14. Chemical switch of a metabotropic glutamate receptor 2 silent allosteric modulator into dual metabotropic glutamate receptor 2/3 negative/positive allosteric modulators.
Schann S; Mayer S; Franchet C; Frauli M; Steinberg E; Thomas M; Baron L; Neuville P
J Med Chem; 2010 Dec; 53(24):8775-9. PubMed ID: 21105727
[TBL] [Abstract][Full Text] [Related]
15. Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research.
Litim N; Morissette M; Di Paolo T
Neuropharmacology; 2017 Mar; 115():166-179. PubMed ID: 27055772
[TBL] [Abstract][Full Text] [Related]
16. Exploring the active conformation of cyclohexane carboxylate positive allosteric modulators of the type 4 metabotropic glutamate receptor.
Rovira X; Harrak Y; Trapero A; González-Bulnes P; Malhaire F; Pin JP; Goudet C; Giraldo J; Llebaria A
ChemMedChem; 2014 Dec; 9(12):2685-98. PubMed ID: 25196639
[TBL] [Abstract][Full Text] [Related]
17. Probing the metabotropic glutamate receptor 5 (mGlu₅) positive allosteric modulator (PAM) binding pocket: discovery of point mutations that engender a "molecular switch" in PAM pharmacology.
Gregory KJ; Nguyen ED; Reiff SD; Squire EF; Stauffer SR; Lindsley CW; Meiler J; Conn PJ
Mol Pharmacol; 2013 May; 83(5):991-1006. PubMed ID: 23444015
[TBL] [Abstract][Full Text] [Related]
18. Opportunities and challenges in drug discovery targeting metabotropic glutamate receptor 4.
Volpi C; Fallarino F; Mondanelli G; Macchiarulo A; Grohmann U
Expert Opin Drug Discov; 2018 May; 13(5):411-423. PubMed ID: 29486616
[TBL] [Abstract][Full Text] [Related]
19. 4-(1-Phenyl-1H-pyrazol-4-yl)quinolines as novel, selective and brain penetrant metabotropic glutamate receptor 4 positive allosteric modulators.
Jimenez HN; Liu KG; Hong SP; Reitman MS; Uberti MA; Bacolod MD; Cajina M; Nattini M; Sabio M; Doller D
Bioorg Med Chem Lett; 2012 May; 22(9):3235-9. PubMed ID: 22465637
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of JNJ-40068782, a new potent, selective, and systemically active positive allosteric modulator of the mGlu2 receptor and its radioligand [3H]JNJ-40068782.
Lavreysen H; Langlois X; Ahnaou A; Drinkenburg W; te Riele P; Biesmans I; Van der Linden I; Peeters L; Megens A; Wintmolders C; Cid JM; Trabanco AA; Andrés JI; Dautzenberg FM; Lütjens R; Macdonald G; Atack JR
J Pharmacol Exp Ther; 2013 Sep; 346(3):514-27. PubMed ID: 23766542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
